Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX
Showing element 1575 to 1624 of 3228 in total
Value Type: Measured
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1575\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna polymerase delta p38 subunit. [source:refseq;acc:nm\_015584]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5106.13\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5472.96\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07184\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1576\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mitochondrial ribosomal protein l30 isoform a. [source:refseq;acc:nm\_145212]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5923.66\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6349.04\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.07181\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1577\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
26s protease regulatory subunit s10b (proteasome subunit p42) (p44) (conserved atpase domain protein 44) (cadp44). [source:swissprot;acc:q92524]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1578\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
proteasome subunit alpha type 4 (ec 3.4.25.1) (proteasome component c9) (macropain subunit c9) (multicatalytic endopeptidase complex subunit c9) (proteasome subunit l). [source:swissprot;acc:p25789]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6213.27\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6659.39\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0718\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1579\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
26s proteasome non-atpase regulatory subunit 12 (26s proteasome regulatory subunit p55). [source:swissprot;acc:o00232]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5842.44\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6261.87\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07179\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1580\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
glycogenin-1 (ec 2.4.1.186). [source:swissprot;acc:p46976]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6376.12\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6833.59\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.07175\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1581\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
adenosine kinase (ec 2.7.1.20) (ak) (adenosine 5'-phosphotransferase). [source:swissprot;acc:p55263]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1582\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein x 0001. [source:refseq;acc:nm\_016302]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1583\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
glycogenin-2 (ec 2.4.1.186) (gn-2) (gn2). [source:swissprot;acc:o15488]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1584\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
glycine dehydrogenase [decarboxylating], mitochondrial precursor (ec 1.4.4.2) (glycine decarboxylase) (glycine cleavage system p- protein). [source:swissprot;acc:p23378]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5933.25\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6358.78\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07172\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1585\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
26s proteasome non-atpase regulatory subunit 13 (26s proteasome regulatory subunit s11) (26s proteasome regulatory subunit p40.5). [source:swissprot;acc:q9unm6]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5858.48\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6278.32\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07166\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1586\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin-like protein smt3c precursor (ubiquitin-homology domain protein pic1) (ubiquitin-like protein ubl1) (ubiquitin-related protein sumo-1) (gap modifying protein 1) (gmp1) (sentrin). [source:swissprot;acc:q93068]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5784.36\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6198.73\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.07164\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1587\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
udp-glucose 6-dehydrogenase (ec 1.1.1.22) (udp-glc dehydrogenase) (udp-glcdh) (udpgdh). [source:swissprot;acc:o60701]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1588\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transcriptional co-repressor sin3a; transcriptional regulator, sin3a (yeast). [source:refseq;acc:nm\_015477]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
3600.99\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
3360.33\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.07162\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1589\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
density-regulated protein (drp) (drp1 protein) (smooth muscle cell associated protein-3) (smap-3). [source:swissprot;acc:o43583]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1590\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
fuse-binding protein-interacting repressor isoform b; siah binding protein 1; pyrimidine tract binding splicing factor; ro ribonucleoprotein-binding protein 1; poly-u binding splicing factor puf60. [source:refseq;acc:nm\_014281]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6364.01\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6819.38\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.07155\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1591\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
multisynthetase complex auxiliary component p38 (jtv-1 protein) (pro0992). [source:swissprot;acc:q13155]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1592\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
26s proteasome non-atpase regulatory subunit 11 (26s proteasome regulatory subunit s9) (26s proteasome regulatory subunit p44.5). [source:swissprot;acc:o00231]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5853.1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6271.79\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07153\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1593\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
proliferating cell nuclear antigen (pcna) (cyclin). [source:swissprot;acc:p12004]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4977.77\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5333.78\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.07152\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1594\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transportin-sr; importin 12. [source:refseq;acc:nm\_012470]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5184.94\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5555.76\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1595\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
proteasome subunit beta type 8 precursor (ec 3.4.25.1) (proteasome component c13) (macropain subunit c13) (multicatalytic endopeptidase complex subunit c13). [source:swissprot;acc:p28062]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6351.32\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6805.39\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07149\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1596\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
enigma protein; lim domain protein. [source:refseq;acc:nm\_005451]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5665.34\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6070.32\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.07148\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1597\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
eukaryotic translation initiation factor 3 subunit 7 (eif-3 zeta) (eif3 p66) (eif3d). [source:swissprot;acc:o15371]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1598\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
lon protease homolog, mitochondrial precursor (ec 3.4.21.-) (lon protease-like protein) (lonp) (lonhs). [source:swissprot;acc:p36776]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5068.17\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5430.41\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.07147\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1599\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
40s ribosomal protein s24 (s19). [source:swissprot;acc:p16632]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5184.45\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5554.97\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1600\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
14.5 kda translational inhibitor protein (p14.5) (uk114 antigen homolog). [source:swissprot;acc:p52758]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6336.22\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6788.96\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07145\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1601\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
spectrin beta chain, brain 2 (spectrin, non-erythroid beta chain 2) (beta-iii spectrin). [source:swissprot;acc:o15020]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5232.14\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5605.8\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.07142\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1602\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
spectrin beta chain, brain 1 (spectrin, non-erythroid beta chain 1) (beta-ii spectrin) (fodrin beta chain). [source:swissprot;acc:q01082]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1603\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
phosphoacetylglucosamine mutase (ec 5.4.2.3) (pagm) (acetylglucosamine phosphomutase) (n-acetylglucosamine-phosphate mutase) (phosphoglucomutase 3). [source:swissprot;acc:o95394]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1604\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
malonyl-coa decarboxylase, mitochondrial precursor (ec 4.1.1.9) (mcd). [source:swissprot;acc:o95822]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6176.82\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6617.91\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.07141\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1605\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
itchy homolog e3 ubiquitin protein ligase; atrophin-1 interacting protein 4; itchy (mouse homolog) e3 ubiquitin protein ligase; nfe2-associated polypeptide 1; ubiquitin protein ligase itch. [source:refseq;acc:nm\_031483]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1606\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
5'-methylthioadenosine phosphorylase (ec 2.4.2.28) (mta phosphorylase) (mtapase). [source:swissprot;acc:q13126]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5232.99\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5606.53\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.07138\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1607\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
putative ribosomal rna methyltransferase 1 (ec 2.1.1.-) (rrna (uridine-2'-o-)-methyltransferase) (jm23 protein). [source:swissprot;acc:q9uet6]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1608\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin. [source:swissprot;acc:p02248]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6158.22\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6597.55\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.07134\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1609\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
26s proteasome non-atpase regulatory subunit 10 (26s proteasome regulatory subunit p28) (gankyrin). [source:swissprot;acc:o75832]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5826.74\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6242.44\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1610\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
eif-5a2 protein. [source:refseq;acc:nm\_020390]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6222.4\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6665.83\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07126\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1611\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cdc42-interacting protein 4 (thyroid receptor interacting protein 10) (trip-10). [source:swissprot;acc:q15642]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5497.73\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5132.35\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07119\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1612\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
eukaryotic translation initiation factor 5a (eif-5a) (eif-4d) (rev- binding factor). [source:swissprot;acc:p10159]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6212.98\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6655.12\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07116\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1613\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mitochondrial 28s ribosomal protein s22 (s22mt) (mrp-s22) (gk002). [source:swissprot;acc:p82650]\vspace{3pt}}&\multirow{7}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6035.6\vspace{3pt}}}&\multirow{7}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6464.5\vspace{3pt}}}&\multirow{7}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.07106\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1614\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nefa-interacting nuclear protein nip30. [source:refseq;acc:nm\_024946]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1615\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
lim homeobox transcription factor 1 alpha (lim/homeobox protein lmx1a) (lim-homeobox protein 1.1) (lmx-1.1). [source:swissprot;acc:q8te12]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1616\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mitochondrial precursor proteins import receptor (translocase of outer membrane tom70). [source:swissprot;acc:o94826]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1617\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
lim homeobox transcription factor 1 beta (lim/homeobox protein lmx1b) (lim-homeobox protein 1.2) (lmx-1.2). [source:swissprot;acc:o60663]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1618\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
proteasome subunit beta type 2 (ec 3.4.25.1) (proteasome component c7-i) (macropain subunit c7-i) (multicatalytic endopeptidase complex subunit c7-i). [source:swissprot;acc:p49721]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1619\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
adp-ribosylation factor-like protein 1. [source:swissprot;acc:p40616]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1620\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
acyl-coa dehydrogenase, short/branched chain specific, mitochondrial precursor (ec 1.3.99.-) (sbcad) (2-methyl branched chain acyl-coa dehydrogenase) (2-mebcad) (2-methylbutyryl-coenzyme a dehydrogenase) (2-methylbutyryl-coa dehydrogenase). [source:swissprot;acc:p45954]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6296.52\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6743.85\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07104\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1621\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
sterile alpha and tir motif containing 1; sterile alpha and heat/armadillo motif protein, ortholog of drosophila. [source:refseq;acc:nm\_015077]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5520.36\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5911.98\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07094\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1622\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
phospholipase d1 (ec 3.1.4.4) (pld 1) (choline phosphatase 1) (phosphatidylcholine-hydrolyzing phospholipase d1) (hpld1). [source:swissprot;acc:q13393]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6153.79\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6589.52\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07081\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1623\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transitional endoplasmic reticulum atpase (ter atpase) (15s mg(2+)- atpase p97 subunit) (valosin containing protein) (vcp) [contains: valosin]. [source:swissprot;acc:p55072]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6449.02\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6905.56\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07079\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1624\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
similar to zinc finger protein 277. [source:sptrembl;acc:q8wwa6]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4102.1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4392.15\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07071\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/